CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic? Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar Long-term Variations of FFR and iFR After Transcatheter Aortic Valve Implantation Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature The Objective Physical Activity and Cardiovascular Disease Health in Older Women (OPACH) Study Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies

Clinical Trial4 Apr 2022

JOURNAL:Circulation. Article Link

Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR: The ADAPT-TAVR Randomized Clinical Trial

D-W Park, J-M Ahn, D-Y Kang et al. Keywords: TAVR; without an indication for long-term anticoagulation; subclinical leaflet thrombosis

Full Text PDF